What are St. Jude Medical's recommendations for the temporary discontinuation of anticoagulation therapy?
In each case, a risk or benefit assessment must be made to determine whether anticoagulant medication should be temporarily discontinued, reduced, or replaced by heparin or another substitute therapy. While St. Jude Medical does not make anticoagulation treatment recommendations, the following studies report on the safety of temporary discontinuation and the resulting thromboembolic rates in patients with mechanical valves.
References
Tinker, et al.: Discontinuing anticoagulant therapy in surgical patients with cardiac valve prostheses. JAMA 1978;239(8):738-739.
Goldenberg, et al.: Safety of temporary discontinuation of oral anticoagulation in patients with St. Jude Medical prosthetic valves. J Am Coll Cardiol 1990;15:237A.
Saour, et al.: Dental procedures in patients receiving oral anticoagulation therapy. J Heart Valve Dis 1994;3(3):315-317.
Stein, et al.: Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves. Chest 1995;108(4 suppl):S371-S379.